Skip to main content
Log in

Noninvasive detection of cardiac amyloidosis using delayed enhanced MDCT: a pilot study

  • Cardiac
  • Published:
European Radiology Aims and scope Submit manuscript

Abstract

Objectives

To evaluate myocardial enhancement of patients with cardiac amyloidosis (CA) using computed tomography (CT).

Methods

Thirteen patients with CA and 11 control patients were examined with first-pass and delayed CT acquisition. A qualitative and quantitative analysis of images was performed. Myocardial attenuation, myocardial signal-to-noise ratio (SNRmyoc), blood pool SNR (SNRblood), contrast-to-noise ratio between blood pool and myocardium (CNRblood-myoc) and relative attenuation index (RAI) defined as variation of myocardial attenuation between delayed and first-pass acquisitions were calculated.

Results

Two false negative cases (15 %) and three false positive cases (27 %) were detected on qualitative analysis. SNRmyoc of patients with CA was significantly (p < 0.05) lower on first-pass (4.08 ± 1.9) and higher on delayed acquisition (7.10 ± 2.7) than control patients (6.1 ± 2.2 and 5.03 ± 1.8, respectively). Myocardial attenuation was higher in CA (121 ± 39 HU) than control patients (81 ± 17 HU) on delayed acquisition. CNRblood-myoc was significantly (p < 0.05) lower in CA (1.51 ± 0.7) than control patients (2.85 ± 1.2) on delayed acquisition. The RAI was significantly (p < 0.05) higher in CA (0.12 ± 0.25) than in control patients (−0.56 ± 0.21).

Conclusion

Dual phase MDCT can detect abnormal myocardial enhancement in patients with CA.

Key points

• CT can detect abnormal first-pass and delayed enhancement in cardiac amyloidosis.

• Measurement of relative myocardial enhancement between acquisitions helps to detect cardiac amyloidosis.

• CT may provide useful data to diagnose cardiac amyloidosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Abbreviations

CA:

Cardiac amyloidosis

CNR:

Contrast-to-noise ratio

CT:

Computed tomography

LGE:

Late gadolinium enhancement

MDCT:

Multidetector computed tomography

RAI:

Relative attenuation index

SNR:

Signal-to-noise ratio

References

  1. Falk RH, Comenzo RL, Skinner M (1997) The systemic amyloidoses. N Engl J Med 337:898–909

    Article  CAS  PubMed  Google Scholar 

  2. Koyama J, Falk RH (2010) Prognostic significance of strain Doppler imaging in light-chain amyloidosis. JACC Cardiovasc Imaging 3:333–342

    Article  PubMed  Google Scholar 

  3. Selvanayagam JB, Hawkins PN, Paul B, Myerson SG, Neubauer S (2007) Evaluation and management of the cardiac amyloidosis. J Am Coll Cardiol 50:2101–2110

    Article  CAS  PubMed  Google Scholar 

  4. Austin BA, Tang WH, Rodriguez ER et al (2009) Delayed hyper-enhancement magnetic resonance imaging provides incremental diagnostic and prognostic utility in suspected cardiac amyloidosis. JACC Cardiovasc Imaging 2:1369–1377

    Article  PubMed  Google Scholar 

  5. Maceira AM, Joshi J, Prasad SK et al (2005) Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation 111:186–193

    Article  PubMed  Google Scholar 

  6. Maceira AM, Prasad SK, Hawkins PN, Roughton M, Pennell DJ (2008) Cardiovascular magnetic resonance and prognosis in cardiac amyloidosis. J Cardiovasc Magn Reson 10:54

    Article  PubMed Central  PubMed  Google Scholar 

  7. Syed IS, Glockner JF, Feng D et al (2010) Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis. JACC Cardiovasc Imaging 3:155–164

    Article  PubMed  Google Scholar 

  8. Vogelsberg H, Mahrholdt H, Deluigi CC et al (2008) Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy. J Am Coll Cardiol 51:1022–1030

    Article  PubMed  Google Scholar 

  9. Mark DB, Berman DS, Budoff MJ et al (2010) ACCF/ACR/AHA/NASCI/SAIP/SCAI/SCCT 2010 expert consensus document on coronary computed tomographic angiography: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. J Am Coll Cardiol 55:2663–2699

    Article  PubMed  Google Scholar 

  10. Montalescot G, Sechtem U, Achenbach S et al (2013) 2013 ESC guidelines on the management of stable coronary artery disease: the task force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J 34:2949–3003

    Article  PubMed  Google Scholar 

  11. Baks T, Cademartiri F, Moelker AD et al (2007) Assessment of acute reperfused myocardial infarction with delayed enhancement 64-MDCT. AJR Am J Roentgenol 188:W135–W137

    Article  PubMed  Google Scholar 

  12. Gerber BL, Belge B, Legros GJ et al (2006) Characterization of acute and chronic myocardial infarcts by multidetector computed tomography: comparison with contrast-enhanced magnetic resonance. Circulation 113:823–833

    Article  PubMed  Google Scholar 

  13. Nieman K, Shapiro MD, Ferencik M et al (2008) Reperfused myocardial infarction: contrast-enhanced 64-Section CT in comparison to MR imaging. Radiology 247:49–56

    Article  PubMed  Google Scholar 

  14. Rodriguez-Granillo GA, Rosales MA, Baum S et al (2009) Early assessment of myocardial viability by the use of delayed enhancement computed tomography after primary percutaneous coronary intervention. JACC Cardiovasc Imaging 2:1072–1081

    Article  PubMed  Google Scholar 

  15. Sato A, Nozato T, Hikita H et al (2012) Prognostic value of myocardial contrast delayed enhancement with 64-slice multidetector computed tomography after acute myocardial infarction. J Am Coll Cardiol 59:730–738

    Article  PubMed  Google Scholar 

  16. Zhao L, Ma X, Delano MC et al (2013) Assessment of myocardial fibrosis and coronary arteries in hypertrophic cardiomyopathy using combined arterial and delayed enhanced CT: comparison with MR and coronary angiography. Eur Radiol 23:1034–1043

    Article  PubMed  Google Scholar 

  17. Dambrin G, Laissy JP, Serfaty JM, Caussin C, Lancelin B, Paul JF (2007) Diagnostic value of ECG-gated multidetector computed tomography in the early phase of suspected acute myocarditis. A preliminary comparative study with cardiac MRI. Eur Radiol 17:331–338

    Article  PubMed  Google Scholar 

  18. Bandula S, Banypersad SM, Sado D et al (2013) Measurement of tissue interstitial volume in healthy patients and those with amyloidosis with equilibrium contrast-enhanced MR imaging. Radiology 268:858–864

    Article  PubMed  Google Scholar 

  19. Banypersad SM, Sado DM, Flett AS et al (2013) Quantification of myocardial extracellular volume fraction in systemic AL amyloidosis: an equilibrium contrast cardiovascular magnetic resonance study. Circ Cardiovasc Imaging 6:34–39

    Article  PubMed  Google Scholar 

  20. Canet EP, Janier MF, Revel D (1999) Magnetic resonance perfusion imaging in ischemic heart disease. J Magn Reson Imaging 10:423–433

    Article  CAS  PubMed  Google Scholar 

  21. Weinmann HJ, Brasch RC, Press WR, Wesbey GE (1984) Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent. AJR Am J Roentgenol 142:619–624

    Article  CAS  PubMed  Google Scholar 

  22. Mahrholdt H, Wagner A, Judd RM, Sechtem U, Kim RJ (2005) Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. Eur Heart J 26:1461–1474

    Article  PubMed  Google Scholar 

  23. Bourin M, Jolliet P, Ballereau F (1997) An overview of the clinical pharmacokinetics of x-ray contrast media. Clin Pharmacokinet 32:180–193

    Article  CAS  PubMed  Google Scholar 

  24. Paul JF, Wartski M, Caussin C et al (2005) Late defect on delayed contrast-enhanced multi-detector row CT scans in the prediction of SPECT infarct size after reperfused acute myocardial infarction: initial experience. Radiology 236:485–489

    Article  PubMed  Google Scholar 

  25. Kartje JK, Schmidt B, Bruners P, Mahnken AH (2013) Dual energy CT with nonlinear image blending improves visualization of delayed myocardial contrast enhancement in acute myocardial infarction. Invest Radiol 48:41–45

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The scientific guarantor of this publication is Jean-François Deux. The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article. The authors state that this work has not received any funding. One of the authors has significant statistical expertise. Institutional review board approval was obtained. Written informed consent was obtained from all subjects (patients) in this study. Methodology: prospective, experimental, performed at one institution.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jean-François Deux.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Deux, JF., Mihalache, CI., Legou, F. et al. Noninvasive detection of cardiac amyloidosis using delayed enhanced MDCT: a pilot study. Eur Radiol 25, 2291–2297 (2015). https://doi.org/10.1007/s00330-015-3642-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00330-015-3642-2

Keywords

Navigation